RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
The high morbidity and mortality of colorectal cancer (CRC) remain a worldwide challenge, despite the advances in prevention, diagnosis, and treatment. RAS alterations have a central role in the pathogenesis of CRC universally recognized both in the canonical mutation-based classification and in the...
Main Authors: | Valeria Maffeis, Lorenzo Nicolè, Rocco Cappellesso |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01255/full |
Similar Items
-
Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer
by: Laurent M. C. Georges, et al.
Published: (2019-06-01) -
Tumor Budding: The Name is EMT. Partial EMT.
by: Alexandru Dan Grigore, et al.
Published: (2016-04-01) -
Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
by: Rita T. Lawlor, et al.
Published: (2019-01-01) -
Role of epithelial mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC): is tumor budding the missing link?
by: Eva eKaramitopoulou
Published: (2013-09-01) -
Tumor Budding Cells, Cancer Stem Cells and Epithelial-Mesenchymal Transition-type Cells in Pancreatic Cancer
by: Eva eKaramitopoulou
Published: (2013-01-01)